A Crowd Sourcing Platform for Patients With Cancer

NCT03530826 · tracked via the Priya Life Science USA tracker

Sponsor

All4Cure

Phase

Observational

Started

2018-04-26

Last updated

2024-07-30

Condition(s) studied

Cancer

Investigational drug(s) / intervention(s)

No intervention

No intervention: No Intervention

Study summary

All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Have been diagnosed with cancer. * Be under the care of a physician. * Be 18 years of age or older. Exclusion Criteria:

Primary outcome measure(s)

Change in tumor tissue molecular profiles — 6 years
Profiles of pre- and post-treatment tumor tissue will be compared.

Trial sites (1)

Facility	City	Region	Status
All4Cure	Seattle	Washington	Recruiting

More All4Cure trials in the USA

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma Active, not recruiting

Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma Recruiting

Other trials for the same condition

A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors Active, not recruiting

Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device Active, not recruiting

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data Recruiting

Collection and Distribution of Biospecimens for Novel Research Uses Recruiting

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02) Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03530826 on ClinicalTrials.gov ↗ ← All trials in the USA